| abstract |
The present invention relates to a compound of formula (I): □ a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable solvate of the same, wherein the substituent is as defined herein; Compositions; and the use of such compounds for the treatment of various diseases, particularly asthma and chronic obstructive pulmonary disease (COPD). |